标题
miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma
作者
关键词
-
出版物
Biomolecules
Volume 11, Issue 11, Pages 1648
出版商
MDPI AG
发表日期
2021-11-08
DOI
10.3390/biom11111648
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- USP22 deficiency in melanoma mediates resistance to T cells through IFNγ-JAK1-STAT1 signal axis
- (2021) Min Li et al. MOLECULAR THERAPY
- Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
- (2021) Diwakar Davar et al. SCIENCE
- Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients
- (2021) Anna Grenda et al. Frontiers in Oncology
- IL-1α Mediates Innate and Acquired Resistance to Immunotherapy in Melanoma
- (2021) Shubhra Singh et al. JOURNAL OF IMMUNOLOGY
- Evolution of delayed resistance to immunotherapy in a melanoma responder
- (2021) David Liu et al. NATURE MEDICINE
- Poor clinical outcome in metastatic melanoma is associated with a microRNA-modulated immunosuppressive tumor microenvironment
- (2020) Natasha A. N. Jorge et al. Journal of Translational Medicine
- Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1
- (2020) Caroline Imbert et al. Nature Communications
- Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild-type advanced non-small cell lung cancer
- (2020) Xiao-Xiao Peng et al. Journal for ImmunoTherapy of Cancer
- Melanoma-Derived Exosomal miR-125b-5p Educates Tumor Associated Macrophages (TAMs) by Targeting Lysosomal Acid Lipase A (LIPA)
- (2020) Dennis Gerloff et al. Cancers
- MicroRNA-9 Fine-Tunes Dendritic Cell Function by Suppressing Negative Regulators in a Cell-Type-Specific Manner
- (2020) Brendan Cordeiro et al. Cell Reports
- Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy
- (2020) Lina Such et al. JOURNAL OF CLINICAL INVESTIGATION
- Reversal of pre-existing NGFR-driven tumor and immune therapy resistance
- (2020) Julia Boshuizen et al. Nature Communications
- The Interplay among miRNAs, Major Cytokines, and Cancer-Related Inflammation
- (2020) Chiranjib Chakraborty et al. Molecular Therapy-Nucleic Acids
- BRAF Inhibitors: Molecular Targeting and Immunomodulatory Actions
- (2020) Ilaria Proietti et al. Cancers
- Mechanisms of Cancer Resistance to Immunotherapy
- (2020) Rilan Bai et al. Frontiers in Oncology
- Hypoxic Melanoma Cells Deliver microRNAs to Dendritic Cells and Cytotoxic T Lymphocytes through Connexin-43 Channels
- (2020) Andrés Tittarelli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review
- (2020) Ilaria Proietti et al. Cancers
- miR-524-5p reduces the progression of the BRAF inhibitor-resistant melanoma
- (2020) Mai-Huong Thi Nguyen et al. NEOPLASIA
- Immunotherapy of melanoma: facts and hopes
- (2019) Sarah A Weiss et al. CLINICAL CANCER RESEARCH
- MicroRNA-155 expression is enhanced by T-cell receptor stimulation strength and correlates with improved tumor control in melanoma
- (2019) Amaia Martinez-Usatorre et al. Cancer Immunology Research
- Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment
- (2019) Hany A. Omar et al. FEBS Journal
- Circulating microRNAs predict the response to anti-PD-1 therapy in non-small cell lung cancer
- (2019) Jinshuo Fan et al. GENOMICS
- Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response
- (2019) Mahnaz Sahraei et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNAs that predict the effectiveness of anti-PD-1 therapies in patients with advanced melanoma
- (2019) Satoshi Nakahara et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma
- (2019) Jonathan A. Trujillo et al. Journal for ImmunoTherapy of Cancer
- MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma
- (2019) Virginie Vignard et al. Cancer Immunology Research
- Serum exosomal microRNAs as potent circulating biomarkers for melanoma
- (2018) Li Tengda et al. MELANOMA RESEARCH
- miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy
- (2018) Jiajia Xi et al. ONCOGENE
- A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
- (2018) Deng Pan et al. SCIENCE
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma
- (2018) Luigi Fattore et al. CELL DEATH AND DIFFERENTIATION
- The effect of cellular context on miR-155-mediated gene regulation in four major immune cell types
- (2018) Jing-Ping Hsin et al. NATURE IMMUNOLOGY
- Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment
- (2018) Shin La Shu et al. Scientific Reports
- miR-146a Controls Immune Response in the Melanoma Microenvironment
- (2018) Justin Mastroianni et al. CANCER RESEARCH
- Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis
- (2018) Biagio Ricciuti et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma
- (2018) Alice Indini et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma
- (2018) Veronica Huber et al. JOURNAL OF CLINICAL INVESTIGATION
- Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway
- (2018) Xiaocheng Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
- (2018) Frank Stephen Hodi et al. LANCET ONCOLOGY
- Loss of miR-155 upregulates WEE1 in metastatic melanoma
- (2018) Julie A. DiSano et al. MELANOMA RESEARCH
- Predictive Biomarkers for Checkpoint Immunotherapy: Current Status and Challenges for Clinical Application
- (2018) Nancy Tray et al. Cancer Immunology Research
- Antitumor immunity is defective in T cell–specific microRNA-155–deficient mice and is rescued by immune checkpoint blockade
- (2017) Thomas B. Huffaker et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
- (2017) Jacob Schachter et al. LANCET
- miR-128 enhances dendritic cell-mediated anti-tumor immunity via targeting of p38
- (2017) Xue Liang et al. Molecular Medicine Reports
- Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de‐differentiated state
- (2017) Mohammad Fallahi‐Sichani et al. Molecular Systems Biology
- Identification of essential genes for cancer immunotherapy
- (2017) Shashank J. Patel et al. NATURE
- In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
- (2017) Robert T. Manguso et al. NATURE
- Targeted agents and immunotherapies: optimizing outcomes in melanoma
- (2017) Jason J. Luke et al. Nature Reviews Clinical Oncology
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
- (2017) Teresa Davoli et al. SCIENCE
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- An NF-κB-microRNA regulatory network tunes macrophage inflammatory responses
- (2017) Mati Mann et al. Nature Communications
- Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
- (2017) Arthur E. Frankel et al. NEOPLASIA
- Melanoma
- (2017) Daniel G. Coit et al. Journal of the National Comprehensive Cancer Network
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- Targeting microRNAs as key modulators of tumor immune response
- (2016) Laura Paladini et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Melanoma miRNA trafficking controls tumour primary niche formation
- (2016) Shani Dror et al. NATURE CELL BIOLOGY
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- Unexpected positive control of NFκB and miR-155 by DGKα and ζ ensures effector and memory CD8+ T cell differentiation
- (2016) Jialong Yang et al. Oncotarget
- miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion
- (2016) Qing Li et al. Oncotarget
- Classifying Cancers Based on T-cell Infiltration and PD-L1
- (2015) Michele W.L. Teng et al. CANCER RESEARCH
- Physiological roles of miR-155
- (2015) Ryuichi Mashima IMMUNOLOGY
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-22 Impairs Anti-Tumor Ability of Dendritic Cells by Targeting p38
- (2015) Xue Liang et al. PLoS One
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Cancer and the microbiota
- (2015) W. S. Garrett SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
- (2015) W. Peng et al. Cancer Discovery
- A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme
- (2015) Gilli Galore-Haskel et al. Oncotarget
- A double feedback loop mediated by microRNA-23a/27a/24-2 regulates M1 versus M2 macrophage polarization and thus regulates cancer progression
- (2015) Sisi Ma et al. Oncotarget
- microRNA-155, Induced by Interleukin-1ß, Represses the Expression of Microphthalmia-Associated Transcription Factor (MITF-M) in Melanoma Cells
- (2015) Nathalie Arts et al. PLoS One
- Host miR155 Promotes Tumor Growth through a Myeloid-Derived Suppressor Cell-Dependent Mechanism
- (2014) S. Chen et al. CANCER RESEARCH
- The role of the microbiota in inflammation, carcinogenesis, and cancer therapy
- (2014) Amiran Dzutsev et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression
- (2014) Regina Lin et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-155 and MicroRNA-21 Promote the Expansion of Functional Myeloid-Derived Suppressor Cells
- (2014) L. Li et al. JOURNAL OF IMMUNOLOGY
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth
- (2014) H Mathsyaraja et al. ONCOGENE
- miR-155 augments CD8+T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γccytokines
- (2014) Yun Ji et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer
- (2013) Jan C. Dudda et al. IMMUNITY
- miR-125a-5p Regulates Differential Activation of Macrophages and Inflammation
- (2013) Sami Banerjee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Pivotal Role of microRNA-155 in the Control of Cancer
- (2013) Zhaolin Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth
- (2013) Yael Nemlich et al. JOURNAL OF CLINICAL INVESTIGATION
- MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation
- (2013) Qiong Li et al. Scientific Reports
- Induction of IL-4R -dependent microRNAs identifies PI3K/Akt signaling as essential for IL-4-driven murine macrophage proliferation in vivo
- (2012) D. Ruckerl et al. BLOOD
- miR-155 regulates IFN- production in natural killer cells
- (2012) R. Trotta et al. BLOOD
- MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages
- (2012) Maliheh Nazari-Jahantigh et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-494 Is Required for the Accumulation and Functions of Tumor-Expanded Myeloid-Derived Suppressor Cells via Targeting of PTEN
- (2012) Y. Liu et al. JOURNAL OF IMMUNOLOGY
- miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1
- (2011) C. Lu et al. BLOOD
- Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D
- (2011) A. Heinemann et al. CANCER RESEARCH
- MicroRNA miR-21 Regulates the Metastatic Behavior of B16 Melanoma Cells
- (2011) Chuan He Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cutting Edge: MicroRNA-181 Promotes Human NK Cell Development by Regulating Notch Signaling
- (2011) F. Cichocki et al. JOURNAL OF IMMUNOLOGY
- MicroRNA-155 targets the SKI gene in human melanoma cell lines
- (2011) Lauretta Levati et al. Pigment Cell & Melanoma Research
- The Interleukin 13 (IL-13) Pathway in Human Macrophages Is Modulated by MicroRNA-155 via Direct Targeting of Interleukin 13 Receptor α1 (IL13Rα1)
- (2010) Rocio T. Martinez-Nunez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update on Immunologic Therapy With Anti–CTLA-4 Antibodies in Melanoma: Identification of Clinical and Biological Response Patterns, Immune-Related Adverse Events, and Their Management
- (2010) Katharina C. Kaehler et al. SEMINARS IN ONCOLOGY
- The Kinase Akt1 Controls Macrophage Response to Lipopolysaccharide by Regulating MicroRNAs
- (2009) Ariadne Androulidaki et al. IMMUNITY
- miR-155: On the Crosstalk Between Inflammation and Cancer
- (2009) Esmerina Tili et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- MicroRNA-146a Feedback Inhibits RIG-I-Dependent Type I IFN Production in Macrophages by Targeting TRAF6, IRAK1, and IRAK2
- (2009) J. Hou et al. JOURNAL OF IMMUNOLOGY
- Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals
- (2009) F. Bazzoni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More